GlassScriptPhysician profile
Kopal Kulkarni
NPI 1013204858
$1,923.44
in general payments reported to CMS, 2019-2025
7 companies · $20.80 in 2025
The $20.80 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.88 · 2020: $297 · 2021: $65.03 · 2022: $841 · 2023: $590 · 2024: $56.34 · 2025: $20.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $570.80 | 2019-2023 | Ekosonic |
| Inari Medical, INC. | $529.82 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $277.71 | 2020 | |
| Angiodynamics, INC. | $271.77 | 2023-2025 | Alphavac, Bioflo |
| Penumbra, INC. | $132.34 | 2022 | |
| Argon Medical Devices, INC. | $74.30 | 2020-2023 | Cleaner |
| Terumo Medical Corporation | $66.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kopal Kulkarni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.